TGFB1 and breast cancer: One meta-analysis found weaker evidence for TGF-β1 869C/T polymorphism and breast cancer risk (Cox et al., 2007), while the other, based on 31 studies, conducted a subgroup analysis to explore the association between 869C/T polymorphisms and HNC risk.